A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis

被引:1
作者
Spoorenberg, A
van der Heijde, D
de Klerk, E
Dougados, M
de Vlam, K
Mielants, H
van der Tempel, H
van der Linden, S
机构
[1] Univ Hosp Maastricht, Div Rheumatol, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands
[2] Univ Hosp Gent, Ghent, Belgium
[3] Grp Hop Cochin, Paris, France
[4] Maasland Hosp, Sittard, Netherlands
关键词
ankylosing spondylitis; functional indexes; outcome; functional capacity; Dougados Functional Index; Bath Ankylosing Spondylitis Functional Index;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine whether the Bath Ankylosing Spondylitis Functional Index (BASFI, score 0-10) or Dougados Functional Index (DFI, score 0-40) is superior in measuring physical function in ankylosing spondylitis (AS) we studied 191 consecutive outpatients with AS in the Netherlands, France, and Belgium. The participating centers are secondary and tertiary referral centers. The external criterion for disease activity (DA) was: both patient and physician assessment of disease activity on a visual analog scale (VAS) and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The external criterion for damage was 2 radiological scores of the spine; BASRI-s (Bath Ankylosing Spondylitis Radiology Index-spine) and a modified SASSS (Stoke Ankylosing Spondylitis Spine Score). Median scores for BASFI and DFI were 2.5 (range 0-10) and 8.5 (range 0-35), respectively. Spearman correlation coefficient between both indexes was 0.89. The average correlation with disease activity variables was 0.42 for BASFI and 0.41 for DFI. For both BASFI and DFI the correlation with BASRI-s was 0.42 and with SASSS 0.36. When distinguishing between patients with high and low disease activity, sensitivity for both indexes was between 76 and 94%, while specificity was between 66 and 87% for all 3 DA measures, Average misclassification between BASFI, DFI and DA was 23 and 27%, respectively. Both BASFI and DFl correlate equally well with disease activity and damage.
引用
收藏
页码:961 / 965
页数:5
相关论文
共 12 条
[1]  
CALIN A, 1994, J RHEUMATOL, V21, P2281
[2]  
Calin A, 1999, J RHEUMATOL, V26, P988
[3]  
CREEMERS MCW, 1993, THESIS U HOSP NIJMEN
[4]  
DOUGADOS M, 1990, J RHEUMATOL, V17, P1254
[5]  
DOUGADOS M, 1988, J RHEUMATOL, V15, P302
[6]  
GARRETT S, 1994, J RHEUMATOL, V21, P2286
[7]  
Ruof J, 1999, J RHEUMATOL, V26, P955
[8]  
Spoorenberg A, 1999, J RHEUMATOL, V26, P997
[9]  
TAYLOR HG, 1991, BRIT J RHEUMATOL, V30, P330
[10]  
vanderHeijde D, 1997, J RHEUMATOL, V24, P2225